[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Florida Myeloma Crowd Community Event: The Role of Maintenance Therapy and Risk of Secondary Cancers

Florida Myeloma Crowd Community Event: The Role of Maintenance Therapy and Risk of Secondary Cancers  image

Florida Myeloma Crowd Community Event: The Role of Maintenance Therapy and Risk of Secondary Cancers

Webinar
event Apr 26, 2022 / 06:30PM - 08:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Dr. Kazandjian, a mulitple myeloma specialist from Sylvester Cancer Comprehensive Center in Miami will join the Florida Myeloma Crowd Community Chapter to discuss the risk of secondary cancers when taking maintenance therapy. What role does maintenance therapy play in the risk of secondary cancers? What role does maintenance therapy play in durable remissions?

This was one of the most highly requested topics so we are excited to learn together! Please join us. 

Schedule & Agenda

Event panelist Audrey Burton-Bethke
06:30 PM
Introductions
Audrey Burton-Bethke
Audrey introduces the agenda of the event and our featured speaker, Dr. Kazandjian.
Event panelist Dr. Dickran Kazandjian
06:35 PM
Presentation
Dr. Dickran Kazandjian
Dr. Dickran Kazandjian shares the role of maintenance therapy and the risk of secondary cancers related with said therapy.
Event panelist Audience
06:55 PM
Questions and Answers
Audience
Ask Dr. Kazandjian your questions regarding this topic!

Speakers & Moderators

The panelist Dickran Kazandjian, MD
Dickran Kazandjian, MD

Dr. Kazandjian’s clinical and translational research interests lie in the treatment of precursor plasma cell disorders including high risk smoldering multiple myeloma and the role of immunotherapy in plasma cell dyscrasias. In addition, he is re-evaluating the role of autologous stem cell transplant (ASCT) in the era of highly efficacious novel-novel drugs, immunotherapy biologics, and cell-based therapies with the hypothesis that certain subsets of patients with myeloma may not benefit by default upfront ASCT.

Read Bio
The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.